Argent Biopharma Limited has released a press release.
Material Revenues Confirmed from Non-Pharma Business Units
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Argent Biopharma
- Cultivation Licence Granted by the Office of Drug Control
- Arrival of First CannEpil Shipment to United Kingdom
- UK Distribution Agreement with Grow Biotech and IPS
- New Distribution Agreements Signed for CannEpil & IMPs
- Agreement for CBD Nutraceuticals Entry into China Market
Later from Argent Biopharma
- Pharma Update - Increased Orders and Clinical Study
- Brazil Distribution Agreement signed for MGC Pharma Products
- Germany, Austria & Switzerland Distribution Agreement Signed
- MGC Research- Effectiveness of Cannabinoids on Brain Cancers
- Additional Information on Ground-breaking Research
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma